Recent Quotes

My Watchlist

Indicators

Biomarin Pharmaceuticals (NQ: BMRN )

94.03 +1.61 (+1.74%)

Streaming Delayed Price Updated: 12:01 PM EST, Dec 4, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	771,867
Open	92.50
Bid (Size)	94.02 (4)
Ask (Size)	94.07 (3)
Prev. Close	92.42
Today's Range	92.26 - 94.16
52wk Range	76.02 - 117.77
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

December 02, 2023

An 11% decline in the Nasdaq Composite over the past two years is an open invitation for opportunistic growth investors to go shopping.

Via The Motley Fool

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

November 09, 2023

Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.

Via InvestorPlace

Performance

YTD	-6.54%	-6.54%
1 Month	+18.14%	+18.14%
3 Month	+3.63%	+3.63%
6 Month	+2.51%	+2.51%
1 Year	-9.18%	-9.18%

More News

3 Promising Biotech Stocks Flying Under the Radar

November 08, 2023

Via InvestorPlace

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake

November 07, 2023

Via Investor's Business Daily

Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday

November 07, 2023

Via Benzinga

Earnings Outlook For Biomarin Pharmaceutical

October 31, 2023

Via Benzinga

4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

November 04, 2023

Via The Motley Fool

Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?

October 27, 2023

Via Benzinga

3 Under-the-Radar Biotech Stocks to Buy in 2023

October 19, 2023

Via The Motley Fool

15 Analysts Have This to Say About Biomarin Pharmaceutical

October 16, 2023

Via Benzinga

Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty

September 28, 2023

Via Benzinga

Are Gene Therapy Stocks The Market's Next Big Winners?

September 25, 2023

Via MarketBeat

What 16 Analyst Ratings Have To Say About Biomarin Pharmaceutical

September 13, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023

September 28, 2023

Via Benzinga

4 Awe-Inspiring Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

September 23, 2023

Via The Motley Fool

Earnings Outlook For Biomarin Pharmaceutical

July 28, 2023

Via Benzinga

What 9 Analyst Ratings Have To Say About Biomarin Pharmaceutical

July 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023

September 18, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session

September 15, 2023

Via Benzinga

Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?

September 15, 2023

Via Investor's Business Daily

4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

September 02, 2023

Via The Motley Fool

4 Unforgettable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

August 12, 2023

Via The Motley Fool

Biomarin's Q2 Beat Street View, Raises Voxzogo Annual Guidance Driven By Global Demand

August 01, 2023

Via Benzinga

Earnings Scheduled For July 31, 2023

July 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023

July 27, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Burlingame

Find A Business

or Browse Listings

Biomarin Pharmaceuticals (NQ: BMRN )

Price and Volume

Top News

Performance

More News